Florida / New York / No Carolina
Ph: 561.316.3330

ColdVentures Unveils First-of-its-Kind, Class 1 FDA Medical Device ColdVest to Prevent Heat-Related Deaths

Portable Vest Protects Military Personnel, Outdoor Workers, Athletes, Students and More Without Requiring Electricity or Refrigeration Created for Rapid Emergency Cooling Before EMS Arrival

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • As heat waves intensify, ColdVentures, a medical device company developing innovative new technologies to combat heat-related deaths, has unveiled ColdVest, a first-of-its-kind, Class 1 FDA portable emergency cooling device to protect people from heat-related brain or organ damage and death before emergency medical services arrive.

With annual heat-related deaths projected to increase 370 percent by 2050, rising temperatures and extreme heat events pose a significant threat to humans. As heat waves intensify, ColdVentures, a medical device company developing innovative new technologies to combat heat-related deaths, has unveiled ColdVest, a first-of-its-kind, Class 1 FDA portable emergency cooling device to protect people from heat-related brain or organ damage and death before emergency medical services arrive.

“Heat-related deaths have been increasing dramatically in recent years, with estimates ranging from tens of thousands to hundreds of thousands of incidents annually worldwide. 2023 alone set a heat death record in the United States. We need to look beyond      treatment methods like ice baths and adopt new technologies to save lives, as heat stroke is preventable in most cases,” said Tracie Wagman, ColdVentures Co-Founder and CEO. “ColdVest is the only portable emergency device available for heat stroke that does not require electricity or refrigeration. Given that people endured, on average, 86 days of health-threatening high temperatures last year globally, ColdVest has the potential to save thousands of lives around the globe each year.”

Heat stroke poses a particularly deadly threat to military personnel performing strenuous activities and wearing heavy gear in scorching environments; outdoor workers including construction crews, farmers and landscapers who are exposed to direct sunlight and high temperatures for long hours; firefighters battling blazes; and athletes training and competing in hot weather conditions. Heat stroke is especially dangerous for young athletes or those unaccustomed to extreme temperatures.

People suffering from heat stroke typically have 30 minutes before suffering permanent harm. In just under three minutes, ColdVest can reduce core body temperatures up to five degrees and stabilize an individual. Using patented endothermic cooling technology, ColdVest does not require electricity, refrigeration, ice or special storage. To use, add three liters of liquid to ColdVest’s integrated bladder, which then spreads throughout the vest to rapidly activate internal cooling chemicals. ColdVest is then placed over the torso of an individual for immediate relief. To learn more, visit coldvest.com.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

VitaFlow Liberty ™ Granted EU CE-MDR Mark

Jeff Lindstrom, President of CardioFlow, stated, "The certification of VitaFlow Liberty by the CE regulatory body under MDR, is a testament to CardioFlow's world-class R&D, quality, and clinical capabilities. This recognition will expedite the global clinical adoption of the VitaFlowTM series along with other innovative products, advancing CardioFlow's globalization strategy. This achievement also positions us to make a more substantial contributions to developments in the field of heart valve interventions, ultimately benefiting patients across the globe."

Inspira Receives 1st Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.

Inspira reports the first units are expected to be shipped in Q4 2024. The Purchase Order follows the recent FDA Clearance of the INSPIRA™ ART100.

Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility

The purchase order includes deliveries for both the 10mL and 50mL specialty copolymer prefillable syringes that will be manufactured at the West Columbia site being acquired from Nephron. This assurance of supply is expected to support the planned expansion of the 503b operations at the Nephron site. The new copolymer syringe technology reflects the pharmaceutical and healthcare industry’s trend toward transitioning injectable drug therapies into innovative polymer prefillable syringes and away from the older glass and standard plastic syringes reports Sharps Technology.

By using this website you agree to accept Medical Device News Magazine Privacy Policy